Scheduled Maintenance

We have scheduled some maintenance on Saturday 4th of May 2024 starting from 10AM CEST and could last for 2 hours. During this maintenance we are expecting our website to be unavailable or not fully functional.

BABCOCK & WILCOX ENTERPR (BW)

US05614L2097 - Common Stock

1.08  +0.02 (+1.89%)

After market: 1.08 0 (0%)

Fundamental Rating

2

BW gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 86 industry peers in the Electrical Equipment industry. BW has a bad profitability rating. Also its financial health evaluation is rather negative. BW does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

In the past year BW has reported negative net income.
In the past year BW has reported a negative cash flow from operations.
BW had negative earnings in 4 of the past 5 years.
BW had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -27.34%, BW is not doing good in the industry: 63.10% of the companies in the same industry are doing better.
The Return On Invested Capital of BW (3.92%) is better than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BW is significantly below the industry average of 10.34%.
The last Return On Invested Capital (3.92%) for BW is above the 3 year average (2.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -27.34%
ROE N/A
ROIC 3.92%
ROA(3y)-9.65%
ROA(5y)-10.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.71%
ROIC(5y)2.91%

1.3 Margins

BW has a better Operating Margin (2.05%) than 64.29% of its industry peers.
BW's Operating Margin has declined in the last couple of years.
The Gross Margin of BW (21.72%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BW has declined.
Industry RankSector Rank
OM 2.05%
PM (TTM) N/A
GM 21.72%
OM growth 3Y-8.73%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.53%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BW is destroying value.
The number of shares outstanding for BW has been increased compared to 1 year ago.
Compared to 5 years ago, BW has more shares outstanding
Compared to 1 year ago, BW has a worse debt to assets ratio.

2.2 Solvency

BW has an Altman-Z score of -1.13. This is a bad value and indicates that BW is not financially healthy and even has some risk of bankruptcy.
BW has a Altman-Z score of -1.13. This is in the lower half of the industry: BW underperforms 70.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.13
ROIC/WACC0.57
WACC6.9%

2.3 Liquidity

BW has a Current Ratio of 1.42. This is a normal value and indicates that BW is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BW (1.42) is worse than 72.62% of its industry peers.
A Quick Ratio of 1.10 indicates that BW should not have too much problems paying its short term obligations.
The Quick ratio of BW (1.10) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.1

2

3. Growth

3.1 Past

The earnings per share for BW have decreased strongly by -158.14% in the last year.
Looking at the last year, BW shows a quite strong growth in Revenue. The Revenue has grown by 15.64% in the last year.
The Revenue has been decreasing by -1.22% on average over the past years.
EPS 1Y (TTM)-158.14%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-3350%
Revenue 1Y (TTM)15.64%
Revenue growth 3Y20.84%
Revenue growth 5Y-1.22%
Revenue growth Q2Q-9.1%

3.2 Future

Based on estimates for the next years, BW will show a very strong growth in Earnings Per Share. The EPS will grow by 47.21% on average per year.
Based on estimates for the next years, BW will show a decrease in Revenue. The Revenue will decrease by -1.54% on average per year.
EPS Next Y93.2%
EPS Next 2Y47.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.87%
Revenue Next 2Y-1.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BW. In the last year negative earnings were reported.
Also next year BW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BW indicates a rather cheap valuation: BW is cheaper than 84.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.37

4.3 Compensation for Growth

BW's earnings are expected to grow with 47.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.21%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BW!.
Industry RankSector Rank
Dividend Yield N/A

BABCOCK & WILCOX ENTERPR

NYSE:BW (5/3/2024, 7:04:01 PM)

After market: 1.08 0 (0%)

1.08

+0.02 (+1.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap96.64M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.34%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 2.05%
PM (TTM) N/A
GM 21.72%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.42
Quick Ratio 1.1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-158.14%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y93.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.64%
Revenue growth 3Y20.84%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y